Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention

Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

January 28, 2005

February 3, 2025

Center for Drug Evaluation and Research

bec1ab26-9d0e-468e-ac35-7797add101ae

Related Documents

Migraine: Developing Drugs for Preventive Treatment

Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
View Details →

Alcoholism: Developing Drugs for Treatment

Guidance DocumentFebruary 12, 2015Center for Drug Evaluation and Research
View Details →

Public Availability of Labeling Changes in "Changes Being Effected" Supplements

Guidance DocumentSeptember 20, 2006Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.